Northwest Biotherapeutics (DE:NBYB)
OTHER OTC:NBYB
NBYB Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
NBYB Stock 12 Month Forecast
There Are No Analyst Ratings for DE:NBYB In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
NBYB Financial Forecast
NBYB Analyst Recommendation Trends
Rating
Oct 13
Mar 14
Aug 15
Strong Buy
0
0
1
Buy
1
2
2
Hold
0
1
1
Sell
0
0
0
Strong Sell
0
0
0
total
1
3
4
Each month's total comprises the sum of three months' worth of ratings.
NBYB Stock Forecast FAQ
What is DE:NBYB’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:NBYB’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:NBYB, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Northwest Biotherapeutics a Buy, Sell or Hold?
Currently, no data Available
What is Northwest Biotherapeutics’s share price target?
Currently, no data Available
What do analysts say about Northwest Biotherapeutics?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Northwest Biotherapeutics?
To buy shares of DE:NBYB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.